Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
SPS Commerce
SPSC
$2.7B
| $23.1M | 0.01% |
259,426
+88,162
| +51% | +$8.17M |
|
1177
Fluor
FLR
$7.08B
| $23.1M | 0.01% |
583,444
+138,369
| +31% | +$6.12M |
|
1178
JB Hunt Transport Services
JBHT
$24.9B
| $23.1M | 0.01% |
118,757
-322,111
| -73% | -$55.3M |
|
1179
SPX Corp
SPXC
$10.9B
| $23.1M | 0.01% |
115,297
+34,906
| +43% | +$7.12M |
|
1180
CALL
Berkshire Hathaway Class B
BRK.B
$1.11T
| $23M | 0.01% |
45,700
+700
| +2% | +$348K |
|
1181
PUT
Chevron
CVX
$386B
| $22.9M | 0.01% |
150,000
-53,100
| -26% | -$8.09M |
|
|
BLD
1182
DELISTED
TopBuild
BLD
| $22.9M | 0.01% |
54,786
+7,632
| +16% | +$3.27M |
|
1183
Zoom
ZM
$31.1B
| $22.8M | 0.01% |
264,261
-5,162
| -2% | -$434K |
|
1184
CALL
TKO Group
TKO
$14.2B
| $22.8M | 0.01% |
109,000
-16,000
| -13% | -$3.11M |
|
|
GRFS
1185
Grifois
GRFS
$5.44B
| $22.8M | 0.01% |
2,434,636
+1,387,783
| +133% | +$12.6M |
|
1186
Warner Music
WMG
$13.1B
| $22.7M | 0.01% |
741,487
-1,119,200
| -60% | -$34.2M |
|
1187
Applied Industrial Technologies
AIT
$13B
| $22.7M | 0.01% |
88,547
-11,697
| -12% | -$2.99M |
|
1188
PUT
Procter & Gamble
PG
$338B
| $22.7M | 0.01% |
158,400
| – | – |
|
1189
PUT
RTX Corp
RTX
$302B
| $22.7M | 0.01% |
123,600
-12,700
| -9% | -$2.21M |
|
|
NBIS
1190
PUT
Nebius Group N.V.
NBIS
$49.1B
| $22.6M | 0.01% |
270,500
-4,500
| -2% | -$466K |
|
1191
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $22.6M | 0.01% |
145,902
+99,899
| +217% | +$15.4M |
|
|
1192
PUT
Berkshire Hathaway Class B
BRK.B
$1.11T
| $22.6M | 0.01% |
45,000
| – | – |
|
1193
XPO
XPO
$23.8B
| $22.6M | 0.01% |
166,120
+5,741
| +4% | +$782K |
|
1194
PUT
AbbVie
ABBV
$442B
| $22.6M | 0.01% |
98,800
| – | – |
|
1195
Madrigal Pharmaceuticals
MDGL
$12.4B
| $22.5M | 0.01% |
38,720
-11,192
| -22% | -$5.72M |
|
1196
PUT
Antero Resources
AR
$11.6B
| $22.4M | 0.01% |
650,000
-881,500
| -58% | -$29.9M |
|
1197
CALL
Applied Materials
AMAT
$417B
| $22.4M | 0.01% |
87,000
-84,900
| -49% | -$20.4M |
|
1198
Urban Outfitters
URBN
$6.8B
| $22.4M | 0.01% |
297,030
+61,298
| +26% | +$4.34M |
|
1199
Hexcel
HXL
$7.6B
| $22.3M | 0.01% |
302,418
-44,738
| -13% | -$3.16M |
|
1200
Maximus
MMS
$2.84B
| $22.3M | 0.01% |
258,604
+34,058
| +15% | +$2.91M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.